Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Stage IV Pancreatic Cancer

Known as: Stage IV Pancreatic Cancer AJCC v6, Stage IV Carcinoma of the Pancreas, Stage IV Pancreatic Cancer AJCC v7 
Cancer may be of any size and has spread to distant organs, such as the liver, lung, and peritoneal cavity (the body cavity that contains most of the… Expand
National Institutes of Health

Related topics

Related topics

11 relations
Epithelial CellsEpitheliumExocrine pancreasGastrointestinal system
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
HALO-109-301: a Phase III trial of PEGPH20 (with gemcitabine and nab-paclitaxel) in hyaluronic acid-high stage IV pancreatic cancer.
The outlook for patients with advanced pancreatic cancer remains poor, despite significant advances in our understanding of… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Review
2009
Review
2009
The pathology and genetics of metastatic pancreatic cancer.
CONTEXT Metastatic disease is the most critical determinant of resectability of pancreatic cancer and accounts for the poor… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative
PurposeTo describe the preclinical basis for further development of 17-dimethyl aminoethylamino-17-demethoxygeldanamycin… Expand
  • figure 1
  • table 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2004
2004
First clinical experience using a 'pathotropic' injectable retroviral vector (Rexin-G) as intervention for stage IV pancreatic cancer.
Metastatic or non-resectable (stage IV) pancreatic cancer has a rapidly fatal outcome (median survival: 3-6 months), thus making… Expand
Is this relevant?
2003
2003
The recombinant anti-EGF receptor immunotoxin 425(scFv)-ETA' suppresses growth of a highly metastatic pancreatic carcinoma cell line.
Pancreatic carcinoma still has the highest mortality rate in comparison to any other malignancy. Major reasons are late detection… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell…
BACKGROUND A prospective, randomized Phase III trial was performed to determine whether, compared with gemcitabine (GEM) alone… Expand
  • figure 1
  • table 2
  • table 1
  • figure 2
  • table 3
Is this relevant?
2002
2002
A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma.
BACKGROUND Patients with metastatic pancreatic carcinoma have a poor survival. Chemotherapy with gemcitabine is the standard… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Antitumor effect of in vivo somatostatin receptor subtype 2 gene transfer in primary and metastatic pancreatic cancer models.
Our previous studies conducted in pancreatic cancer models established in nude mice and hamsters revealed that cloned… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma.
BACKGROUND Pancreatic carcinoma is considered among the most chemoresistant of human malignancies. The most commonly used… Expand
Is this relevant?
1991
1991
Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia.
In order to determine the efficacy and safety of ancrod, a rapid acting defibrinogenating drug, for patients with heparin-induced… Expand
  • table 1
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE